These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 4125041

  • 1. M.I.F.: effect on levodopa dyskinesias in man.
    Woods AC, Chase TN.
    Lancet; 1973 Sep 01; 2(7827):513. PubMed ID: 4125041
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Coupling of hypotensive and anit-Parkinson effects with two dopaminergic drugs.
    Düby SE, Dahl LK, Cotzias GC.
    Trans Assoc Am Physicians; 1971 Sep 01; 84():289-96. PubMed ID: 5164305
    [No Abstract] [Full Text] [Related]

  • 8. "On-off" phenomenon with levodopa therapy in Parkinsonism. Clinical and pharmacologic correlations and the effect of intramuscular pyridoxine.
    Fahn S.
    Neurology; 1974 May 01; 24(5):431-41. PubMed ID: 4857104
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Indications and results of monoamine treatment in parkinsonian syndromes].
    Boudin G, Pépin B, Guillard A, Fabiani JM, Haguenau M.
    Rev Neurol (Paris); 1972 Jul 01; 127(1):79-97. PubMed ID: 4520464
    [No Abstract] [Full Text] [Related]

  • 14. [Modern treatment of parkinsonism].
    Birkmayer W, Neumayer E.
    Z Neurol; 1972 Jul 01; 202(4):257-80. PubMed ID: 4117647
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Therapeutic guidelines and side effects encountered during L-dopa therapy in 100 cases of parkinsonism.
    Jenkins AC, Schwieger AC.
    Med J Aust; 1971 Oct 02; 2(14):693-700. PubMed ID: 5114186
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Treatment of Parkinson's disease with carbidopa, a peripheral decarboxylase inhibitor, and levodopa.
    Fermaglich J.
    Med Ann Dist Columbia; 1974 Dec 02; 43(12):587-91. PubMed ID: 4532167
    [No Abstract] [Full Text] [Related]

  • 20. Treatment of Parkinsonism with a combination of levodopa and the decarboxylase inhibitor and RO 46-4602 (a comparison with levodopa treatment alone).
    Dupont E, Hansen E, Melsens S, Parkenberg H, Holm P.
    Acta Neurol Scand Suppl; 1972 Dec 02; 51():115-7. PubMed ID: 4514334
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.